InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Breber Sandra, Chief Executive Officer. Director active across 2 companies, notably Augmedix, Inc.. Cumulatively, 2 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €86k. Activity tracked since 28 October 2021. The latest transaction was filed on 28 October 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
12,500 shares@ US$4.0050.0% of flowCommon StockSEC:0001213900-21-055926:0
Ideal exit: 25 Jul 2022 (T+270)
12,500 shares@ US$4.00100.0% of flowCommon StockSEC:0001213900-21-055926
Ideal exit: 25 Jul 2022 (T+270)
2 of 2 declarations
About Breber Sandra
Sandra Breber is the Chief Operating Officer at Augmedix, Inc. She is responsible for managing operations and implementing growth strategies. Her role is essential for ensuring the company's efficiency and profitability.
